Literature DB >> 1699650

Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy.

R W Carlson1, R F Dorfman, B I Sikic.   

Abstract

Thymic carcinomas are rare malignant neoplasms of the thymic epithelium that are distinguished from the malignant thymomas by the presence of cytologic atypia. Thymic carcinomas may metastasize outside of the thorax and are associated with a very poor prognosis. Complete responses of thymic carcinoma to chemotherapy alone have not been reported. A 21-year-old man with metastatic undifferentiated carcinoma of probable thymic origin is presented who achieved a pathologic complete response with cisplatin, vinblastine, and bleomycin chemotherapy. Additional consolidative chemotherapy with cisplatin and etoposide was administered. The patient remains disease-free 5 years after diagnosis. Cisplatin, vinblastine, and bleomycin chemotherapy appears to have significant activity against thymic carcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699650     DOI: 10.1002/1097-0142(19901115)66:10<2092::aid-cncr2820661008>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Salvage chemotherapy with amrubicin and platinum for relapsed thymic carcinoma: experience in six cases.

Authors:  Tomonobu Koizumi; Toshihiko Agatsuma; Takashi Ichiyama; Toshiki Yokoyama; Atsuhito Ushiki; Yoshimichi Komatsu; Tsuyoshi Tanabe; Takashi Kobayashi; Sumiko Yoshikawa; Masanori Yasuo; Hiroshi Yamamoto; Keishi Kubo; Tsutomu Hachiya
Journal:  Med Oncol       Date:  2009-05-05       Impact factor: 3.064

Review 2.  Thymic carcinoma successfully resected with superior vena cava after chemoradiotherapy.

Authors:  Y Shintani; M Ohta; K Hazama; S Miyoshi; K Kagisaki; H Matsuda
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-12

3.  Malignant thymoma with direct invasion into the peritoneal cavity: report of a case.

Authors:  T Fujikawa; Y Nakamura; S Matsusue; H Takeda; Y Kori; M Sonobe
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

4.  Stereotactic ablative radiotherapy with CyberKnife for advanced thymic carcinoma: a case report.

Authors:  C Y Fan; W Y Huang; Y M Jen; M J Lin; K T Lin
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.